Anxiety Disorders

  Examine Plight Study: A Middle-Aged Caucasian Man After a while Anxiety. You terminate be asked to frame three resolutions relating the medication to dictate to this client. Be firm to investigate factors that influence application the client’s pharmacokinetic and pharmacodynamic processes. At each resolution subject-matter plug to entire the following: Decision #1 Which resolution did you choice? Why did you choice this resolution? Support your acceptance after a while exemplification and references to the Learning Resources. What were you hoping to terminate by making this resolution? Support your acceptance after a while exemplification and references to the Learning Resources. Explain any dissent among what you expected to terminate after a while Resolution #1 and the results of the resolution. Why were they irrelative? Decision #2 Why did you choice this resolution? Support your acceptance after a while exemplification and references to the Learning Resources. What were you hoping to terminate by making this resolution? Support your acceptance after a while exemplification and references to the Learning Resources. Explain any dissent among what you expected to terminate after a while Resolution #2 and the results of the resolution. Why were they irrelative? Decision #3 Why did you choice this resolution? Support your acceptance after a while exemplification and references to the Learning Resources. What were you hoping to terminate by making this resolution? Support your acceptance after a while exemplification and references to the Learning Resources. Explain any dissent among what you expected to terminate after a while Resolution #3 and the results of the resolution. Why were they irrelative?   Begin Zoloft 50 mg orally daily RESULTS OF DECISION POINT ONE Client income to clinic in indecent weeks Client informs you that he has no tightness in chest, or neglect of breath Client states that he noticed lowerd worries encircling operation balance the elapsed 4 or 5 days HAM-A score has lowerd to 18 (favoring acceptance) Decision Subject-matter Two Increase dose to 75 mg orally daily RESULTS OF DECISION POINT TWO Client income to clinic in indecent weeks Client reports an uniform advance contraction in his symptoms HAM-A score has now lowerd to 10. At this subject-matter- abide prevalent dose (61% contraction in symptoms) Decision Subject-matter Three Maintain prevalent dose Guidance to Student At this subject-matter, it may be mismisappropriate to abide client at the prevalent dose. It is disengaged that the client is having a good-tempered-tempered acceptance (as exemplificationd by main than a 50% contraction in symptoms) and the client is prevalently not experiencing any plane possessions, the prevalent dose can be maintained for 12 weeks to evaluate ample property of refuse. Increasing refuse at this subject-matter may let-go a advance lower in symptoms, but may as-well acception the waste of plane possessions. This is a resolution that the PMHNP should debate after a while the client. Nothing in the client’s plight tells us that we should investigate adding an enlargement substitute at this subject-matter as the client is demonstrating acceptance to the refuse. Avoid polypharmacy unless symptoms cannot be managed by a one refuse.